Immunologic Research

, Volume 44, Issue 1–3, pp 169–178 | Cite as

Hematopoietic stem cell transplantation for pediatric patients with primary immunodeficiency diseases at All Children’s Hospital/University of South Florida

  • A. Petrovic
  • M. Dorsey
  • J. Miotke
  • C. Shepherd
  • N. Day
Article

Abstract

We retrospectively analyzed the transplantation outcomes of 31 patients with primary immunodeficiency diseases treated at our center (All Children’s Hospital, University of South Florida) since its inception in 1986. The primary immune diseases included severe combined immunodeficiency, Wiscott–Aldrich syndrome, X-linked hyper-IgM syndrome, and chronic granulomatous disease. The age of the patient’s at the time of transplant ranged from 1 month to 19 years, and conditioning regimens varied based on the patients underlying disease. In 23 patients, the graft source was bone marrow, 4 patients received umbilical cord blood grafts and 4 patients received peripheral blood stem cell grafts. Better survival rates were observed in those patients transplanted at a younger age and free of infections, demonstrating that transplantation at an early age before significant infections, autoimmune manifestation and malignant transformation have occurred is beneficial.

Keywords

Primary immunodeficiency disease Hematopoietic stem cell transplantation Outcome Graft versus host disease 

References

  1. 1.
    Gatti RA, Meuwissen HJ, Good RA. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet. 1968;2:1336–9.Google Scholar
  2. 2.
    Dworetzky M, Cohen S. The allergy archives. J Allergy Clin Immunol. 2004;793–800.Google Scholar
  3. 3.
    Bhattacharya A, Slatter MA, Chapman CE, et al. Cord blood stem cell single centre experience of umbilical cord stem cell transplantation for primary immunodeficiency. Bone Marrow Transplant. 2005;36:295–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Knutsen AP, Wall DA. Umbilical cord blood transplantation in severe T-cell Immunodeficiency disorders: two-year experience. J Clin Immunol. 2000;20:466–76.PubMedCrossRefGoogle Scholar
  5. 5.
    Veys P, Rao K, Amrolia P. Stem cell transplantation for congenital immunodeficiencies using reduced-intensity conditioning. Bone Marrow Transplant. 2005;35:S45–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Amrolia P, Gaspar HB, Hassan A, et al. Nonmyeloablative stem cell transplantation for congenital immunodeficiencies. Blood. 2000;96(4):1239–46.PubMedGoogle Scholar
  7. 7.
    Muller SM, Ege M, Pottharst A, et al. Transplacentally acquired maternal T lymphocytes in severe combined immunodeficiency: a study of 121 patients. Blood. 2001;98(6):1847–57.PubMedCrossRefGoogle Scholar
  8. 8.
    Small T. Hematopoietic stem cell transplantation for severe combined immunodeficiency disease. Immunol Allergy Clin North Am. 2000;20(1):207–220.CrossRefGoogle Scholar
  9. 9.
    Markert ML, Hummell DS, Rosenblatt HM, et al. Complete DiGeorge syndrome: persistence of profound immunodeficiency. J Pediatr. 1998;132(1):15–21.Google Scholar
  10. 10.
    Tsuji Y, Imai K, Kajiwara M, et al. Hematopoietic stem cell transplantation for 30 patients with primary immunodeficiency diseases: 20 years experience of a single team. Bone Marrow Transplant. 2006;37:469–477.PubMedCrossRefGoogle Scholar
  11. 11.
    Antoine C, Muller S, Cant A, et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–1999. Lancet. 2003;361:553–60.PubMedCrossRefGoogle Scholar
  12. 12.
    Sato T, Kobayashi R, Toita N, et al. Stem cell transplantation in primary immunodefiency disease patients. Pediatr Int. 2007;49:795–800.PubMedCrossRefGoogle Scholar
  13. 13.
    Friedrich W, Muller SM. Allogeneic stem cell transplantation for treatment of immunodeficiency. Springer Semin Immun. 2004;26:109–18.CrossRefGoogle Scholar
  14. 14.
    Neven B, Leroy S, Decaluwe H, et al. Long-term outcome after haematopoietic stem cell transplantation of a single-centre cohort of 90 patients with severe combined immunodeficiency: long-term outcome of HSCT in SCID. 2009; doi:10.1182/blood09.177923.
  15. 15.
    Buckley RH, Schiff SE, Schiff RI. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med. 1999;340:508–16.PubMedCrossRefGoogle Scholar
  16. 16.
    Grunebaum E, Mazzolari E, Porta F, et al. Bone marrow transplantation for severe combined immune deficiency. Jama. 2006;295:508–18.PubMedCrossRefGoogle Scholar
  17. 17.
    Borghans JA, Bredius RG, Hazenberg MD. Early determinants of long-term T-cell reconstitution after hematopoietic stem cell transplantation for severe combined immunodeficiency. Blood. 2006;108:763–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Patel DD, Gooding ME, Parrott RE, et al. Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med. 2000;342:1325–32.PubMedCrossRefGoogle Scholar
  19. 19.
    Horn B, Viele M, Mentzer W, et al. Autoimmune hemolytic anemia in patients with SCID after T-cell-depleted BM and PBSC transplantation. Bone Marrow Transplant. 1999;24:1009–13.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • A. Petrovic
    • 1
    • 2
  • M. Dorsey
    • 2
  • J. Miotke
    • 1
  • C. Shepherd
    • 1
  • N. Day
    • 2
  1. 1.Department of Blood and Marrow TransplantationAll Children’s HospitalSt. PetersburgUSA
  2. 2.Department of PediatricsUniversity of South FloridaSt. PetersburgUSA

Personalised recommendations